Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-13 of 13 for your search:
Drug:  ibritumomab tiuxetan
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: IDEC-106-04, MAYO-977802

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IDEC-106-06, MAYO-987804, UCLA-9808026

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 307940/106-20, NCT00322218

4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-9804024, IDEC-106-05, NCI-G99-1614

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCI #03-005, NCT00177554

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 59
Sponsor: Other
Protocol IDs: 2007.462, NCT00498043

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: GELTAMO-LCM-04-02, 2005-004400-37, NCT00505232

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: HO04405, NCT00582166

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: DSHNHL 2004-R4, NCT00521560

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: CHUBX 2007/11, NCT00607854

11.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: ZAR2007, NCT00662948

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067697, UAB-9930, IDEC-106-98, GUMC-00095, NCI-G00-1731, NCT00005592

13.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 65 and over
Sponsor: Other
Protocol IDs: SAKK 37/05, SWS-SAKK-37/05, EU-20648, SPRI-SWS-SAKK-37/05, CDR0000511915, NCT00392691
New Search